Biomaterials specialized company

ACE BIOPHARM

We have the solution you need

History

2023

- Registered 12 new DMF products and filed 11 new drug approvals
- Reached USD 81.2 million in sales
- Launching of Ashland's Pharmaceutical Excipients product

<2023 Patent Registration
Patent No. : No. 10-2501636
Invention Name: Manufacturing method and oral tablet including phenoflibrinic acid
Patentee: Ace Biopharm and Yonsei University Industry-Academic Cooperation Center

2022

- Approved DMF registration for a total of 187 APIs
(Approved DMF registration for 25 APIs in 2022)
- Relocation of head office B/D(Bangbae-dong)
(22.08.14)
- 2022 Turn over : 100.3 billion won

2021

Approval on DMF registration of 162 products
Generate over 86.3 milion dollar of sales
Changed company name : Ace Biopharm Co., Ltd.
Certification as Family-friendly company
Certification as an excellent employment stability company
ISO and FSSC 22000 Certification at Pyeongtaek plant
Certification of Global Small-Giants Company

2020

Designated as a Hi Seoul Brand Company
Designated as a Youth-friendly small giant
Designated as a Promising Export Firm

2019

M&A Acebiotech
Established a BIO Research Center in Daejeon
Generated 71 billion won of sales
Won the grand prize for 2019 Korea win-win development

2018

Registered DMF 79 items
Generated 58 billion won of sales
Established a Research Institute
Certified as a KGIP laboratory
Registered 3 patents related to Vitamin K2 production and applied for 1 patent

2017

Registered DMF 60 items
Generated 55 billion won of sales
Extended Logistics Center
Designated as a small giant and excellent technology competency

2016

Moved into Dongjin Pharma owned building
Generated 50 billion won of sales

2015

Registered DMF 40 items
Certified a member of MAINBIZ (MAINBIZ is the certification for managerial innovative company in Korea)
Generated 30 billion won of sales

2014

Generated 20 billion won of sales

2011

Established an affiliate company, Ace Biotech

2009

Generated 11 billion won of sales
Signed exclusive supply contracts with over 20 companies with over 20 items

2004

Established Dongjin Pharma

[06784] 41, Dongsan-ro 8-gil, Seocho-gu, Seoul, Republic of Korea
CEO : Min-Byoung Gyu /  TEL : +82-2-579-1056  /  FAX : +82-2-6008-3356  /  E-mail : ace@acebiopharm.com

Copyright © 2010 ABP company. All Rights Reserved.